. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anticholesteremic Agents/adverse effectsAnticholesteremic Agents/pharmacologyAnticholesteremic Agents/therapeutic useBenzimidazoles/adverse effectsBenzimidazoles/pharmacologyBenzimidazoles/therapeutic useCholesterol, LDL/bloodDrug ApprovalHomozygoteHumansHyperlipoproteinemia Type II/drug therapyHyperlipoproteinemia Type II/physiopathologyOligonucleotides/adverse effectsOligonucleotides/pharmacologyOligonucleotides/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Anticholesteremic AgentsBMS201038BenzimidazolesCholesterol, LDLOligonucleotidesmipomersen
Year: 2013 PMID: 23545581
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN: 0025-732X Impact factor: 1.909